المؤلفون: Alexandra Valeska Matter, Simone M. Goldinger, Sara Micaletto, Ursula Urner-Bloch, Reinhard Dummer

المساهمون: University of Zurich, Dummer, Reinhard

المصدر: The Oncologist

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, 0301 basic medicine, Neuroblastoma RAS viral oncogene homolog, MAPK/ERK pathway, Cancer Research, Skin Neoplasms, medicine.medical_treatment, 610 Medicine & health, Drug resistance, GTP Phosphohydrolases, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Immune system, Cell Line, Tumor, Humans, Medicine, 1306 Cancer Research, Melanoma, Protein Kinase Inhibitors, Aged, business.industry, Kinase, 10177 Dermatology Clinic, Membrane Proteins, Binimetinib, medicine.disease, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Mutation, Cancer research, 2730 Oncology, Precision Medicine Clinic: Molecular Tumor Board, Benzimidazoles, Female, business

وصف الملف: 855_Matter_A._et_al._Long-Term_response_to_intermittent_binimetinib_in_patients_with_NRAS-mutant_Melanoma_the_Oncologist_2020.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145601bc949f4b0f83188d4b388aa2acTest
https://doi.org/10.1634/theoncologist.2019-0656Test

المؤلفون: Zeynep Eroglu, Lauren E. Haydu, George D. Grass, Robert M. Conry, Jessica L. Smith, Simone M. Goldinger, Mark Shackleton, Matteo S. Carlino, Ashlyn S. Everett, Isabella C. Glitza, Douglas B. Johnson, Rachel Roberts-Thomson, Romany A. N. Johnpulle, Peter Koelblinger, Alexander Guminski, Serigne Lo, Georgina V. Long, Rony Kapoor, Ines Pires da Silva, Patricia Banks, Victoria Atkinson, Wei Wang, Alexander M. Menzies, Michael Millward, Angela Hong

المصدر: Pigment Cell Melanoma Res

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Ipilimumab, Dermatology, Antibodies, Article, General Biochemistry, Genetics and Molecular Biology, Cohort Studies, Necrosis, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, medicine, Humans, Cumulative incidence, Radiation Injuries, Melanoma, business.industry, Incidence, Incidence (epidemiology), Brain, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Survival Analysis, Radiation therapy, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Multivariate Analysis, Cohort, Female, Neurosurgery, Radiology, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f18946bddd2aec8b60a7eecf640116Test
https://doi.org/10.1111/pcmr.12775Test

المؤلفون: Nadia Plantier, Sabrina A. Hogan, Simone M. Goldinger, Marieke I.G. Raaijmakers, Anais Courtier, Jean-François Mouret, Thi Dan Linh Nguyen-Kim, Phil F. Cheng, John B. A. G. Haanen, Mitchell P. Levesque, Solène Perez, Pia Kvistborg, Reinhard Dummer, Nicoletta F Jaberg-Bentele, Manuarii Manuel, Nicolas Pasqual

المساهمون: University of Zurich, Levesque, Mitchell P

المصدر: Cancer Immunology Research

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Immunology, Receptors, Antigen, T-Cell, 610 Medicine & health, chemical and pharmacologic phenomena, Antibodies, Monoclonal, Humanized, Peripheral blood mononuclear cell, 03 medical and health sciences, symbols.namesake, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, CTLA-4 Antigen, 1306 Cancer Research, Progression-free survival, Melanoma, Fisher's exact test, Aged, 2403 Immunology, Receiver operating characteristic, 10042 Clinic for Diagnostic and Interventional Radiology, business.industry, T-cell receptor, 10177 Dermatology Clinic, Immunotherapy, Middle Aged, medicine.disease, Ipilimumab, Progression-Free Survival, 3. Good health, 030104 developmental biology, 030220 oncology & carcinogenesis, Monoclonal, symbols, Female, business

وصف الملف: Peripheral_blood_TCR_repertoire_profiling_may_facilitate.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2183a0c56e9ee4715bc5ea53f32f0b44Test
https://doi.org/10.1158/2326-6066.cir-18-0136Test

المؤلفون: Dirk Schadendorf, Carmen Loquai, Felix Kiecker, Konstantin Drexler, Laura Susok, Peter Mohr, Katharina C. Kähler, Leonie Bluhm, Lydia Reinhardt, Friedegund Meier, Jessica C. Hassel, Selma Ugurel, Claudia Pföhler, Sarah Knispel, Bastian Schilling, Christopher G. Cann, Simone M. Goldinger, Elisabeth Livingstone, Andreas Stang, Thomas Eigentler, Cindy Franklin, Julia K. Tietze, Maria Isabel Fleischer, Carola Berking, Paolo A. Ascierto, Judith Sirokay, Carsten Weishaupt, Patrick Schummer, Lisa Zimmer, Georgina V. Long, Maximilian Gassenmaier, Carina N. Owen, Lucie Heinzerling, Raphael R. Reinhard, Douglas B. Johnson, Kai Martin Thoms, Alexander M. Menzies, Dennis Niebel, Ralf Gutzmer

المصدر: European journal of cancer (Oxford, England : 1990). 148

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, Gastroenterology, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Prospective cohort study, Immune Checkpoint Inhibitors, Melanoma, Aged, Retrospective Studies, business.industry, Confounding, Retrospective cohort study, Middle Aged, medicine.disease, Prognosis, Immune checkpoint, 3. Good health, Blockade, Survival Rate, 030104 developmental biology, Oncology, CTLA-4, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Female, Immunotherapy, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7b5b295efc1524ab0bf2996f38c02fTest
https://pubmed.ncbi.nlm.nih.gov/33735811Test

المؤلفون: Joanna Mangana, Mirjam C. Naegeli, Marjam J. Barysch, Simone M. Goldinger, Ralph P. Braun, Anna L. Frauchiger, Daniel Franzen, Mirjana Urosevic-Maiwald, Jivko Kamarachev, Reinhard Dummer, Florentia Dimitriou

المساهمون: University of Zurich, Dummer, Reinhard

المصدر: Melanoma Research

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Sarcoidosis, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 610 Medicine & health, Dermatology, Disease, Targeted therapy, 2708 Dermatology, 030207 dermatology & venereal diseases, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Cancer immunotherapy, medicine, melanoma, Humans, 1306 Cancer Research, Adverse effect, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, Melanoma, 10177 Dermatology Clinic, Retrospective cohort study, Middle Aged, medicine.disease, ORIGINAL ARTICLES: Clinical research, targeted therapy, Oncology, 030220 oncology & carcinogenesis, sarcoid-like reaction, 2730 Oncology, Immunotherapy, 10178 Clinic for Pneumology, business

وصف الملف: 755_Dimitriou_F._et_al._Sarcoid-like_reactions_in_patients_receiving_modern_melanoma_treatment_Melanoma_Res._2018.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338a9ad98b357f816497b9c7ee261928Test
http://europepmc.org/articles/PMC5929490Test

المؤلفون: Carsten Weishaupt, Michael Geier, Andrea Forschner, Friedegund Meier, Ursula Dietrich, Jessica C. Hassel, Patrick Clemens, Markus Hecht, Stephan Grabbe, Ralf Gutzmer, Bülent Polat, Ricarda Rauschenberg, Carmen Loquai, Rainer Fietkau, Felix Kiecker, Lisa Zimmer, Carola Berking, Dirk Schadendorf, Simone M. Goldinger, Gerhard G. Grabenbauer, Luitpold Distel, Gerold Schuler, Jochen Utikal, Lucie Heinzerling, Panagiotis Balermpas

المصدر: British Journal of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Radiation-Sensitizing Agents, Skin Neoplasms, medicine.medical_treatment, Medizin, Cohort Studies, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Vemurafenib, Prospective cohort study, Melanoma, Aged, 80 and over, Imidazoles, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Adolescent, Drug Administration Schedule, BRAF, 03 medical and health sciences, Young Adult, Internal medicine, medicine, Humans, ddc:610, dabrafenib, Protein Kinase Inhibitors, radiotherapy, Aged, Retrospective Studies, business.industry, Dabrafenib, Retrospective cohort study, medicine.disease, Radiation therapy, radiation, 030104 developmental biology, Concomitant, Clinical Study, Skin cancer, business

وصف الملف: application/octet-stream

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e8f1dc9f3855c01558c2eeec19ddedTest
http://europepmc.org/articles/PMC5886123Test

المؤلفون: Kevin B. Kim, Oliver Krieter, David F. McDermott, Keith T. Flaherty, Lyhping Lam, Shefali Kakar, Benjamin Izar, F. Stephen Hodi, Michael B. Atkins, Donald P. Lawrence, Simone M. Goldinger, William H. Sharfman, Reinhard Dummer, Ravi K. Amaravadi, Z. Tang, Jeffrey A. Sosman, Igor Puzanov

المصدر: Cancer Medicine

مصطلحات موضوعية: Placental growth factor, Oncology, Male, Cancer Research, Pathology, Angiogenesis, Pyridines, medicine.medical_treatment, 0302 clinical medicine, 030212 general & internal medicine, Molecular Targeted Therapy, Neoplasm Metastasis, BRAF wild‐type, Biomarker analysis, Melanoma, Original Research, Aged, 80 and over, Imidazoles, Middle Aged, Treatment Outcome, 030220 oncology & carcinogenesis, BRAF‐mutant, Immunohistochemistry, Female, Drug Monitoring, metastatic melanoma, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, Maximum Tolerated Dose, Antineoplastic Agents, 03 medical and health sciences, Pharmacokinetics, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, RAF265, Adverse effect, Protein Kinase Inhibitors, Aged, Neoplasm Staging, business.industry, Growth factor, Clinical Cancer Research, medicine.disease, Pharmacodynamics, Mutation, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11750763d2c877bc35ec8877ec9195bTest
http://europepmc.org/articles/PMC5548886Test

المؤلفون: Silvia A. Haueis, Ralph P. Braun, Mitchell P. Levesque, Simone M. Goldinger, Mirjana Urosevic-Maiwald, Joanna Mangana, Phil F. Cheng, Pascale Kränzlin, Reinhard Dummer

المساهمون: University of Zurich, Goldinger, Simone M

المصدر: Melanoma Research. 27:231-237

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, BRAF inhibitor, medicine.medical_treatment, Targeted therapy, 0302 clinical medicine, Modified recist, 1306 Cancer Research, Melanoma, Aged, 80 and over, Brain Neoplasms, 10177 Dermatology Clinic, Neoplasms, Second Primary, Middle Aged, Prognosis, Phenotype, Survival Rate, 030220 oncology & carcinogenesis, Distribution pattern, Disease Progression, 2730 Oncology, Female, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, 610 Medicine & health, Dermatology, 2708 Dermatology, Young Adult, 03 medical and health sciences, Text mining, Internal medicine, medicine, Humans, Neoplasm Invasiveness, In patient, Protein Kinase Inhibitors, Aged, Retrospective Studies, business.industry, medicine.disease, 030104 developmental biology, Case-Control Studies, business, Follow-Up Studies

وصف الملف: 684_Haueis_S._et_al._Does_the_distribution_pattern_of_brain_metastases_during_BRAF_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8487ec9a6452542b2955e97293575dTest
https://doi.org/10.1097/cmr.0000000000000338Test

المؤلفون: Lars E. French, Simone M. Goldinger, Reinhard Dummer, Pascale Kränzlin-Stieger, Carla Murer

المساهمون: University of Zurich, Murer, Carla

المصدر: Melanoma Research. 27:396-398

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Dacarbazine, medicine.medical_treatment, 610 Medicine & health, Ipilimumab, Dermatology, 2708 Dermatology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, 1306 Cancer Research, Melanoma, neoplasms, Advanced melanoma, business.industry, 10177 Dermatology Clinic, Imatinib, Immunotherapy, Middle Aged, medicine.disease, Proto-Oncogene Proteins c-kit, Pyrimidines, 030104 developmental biology, Nilotinib, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, 2730 Oncology, business, Progressive disease, medicine.drug

وصف الملف: 702_Murer_C._et_al._Successful_treatment_with_imatinib_after_nilotinib_and_ipilimumab_in_a_Melanoma_Res._2017.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f877a2c640b7cb849a1e1f4ace3d08Test
https://doi.org/10.1097/cmr.0000000000000358Test

المؤلفون: Ralf Gutzmer, Claus Garbe, Hira Rizvi, Alisa Y. Kane, Luke Ardolino, Paolo A. Ascierto, Ogochukwu M. Ezeoke, Victoria Atkinson, Alexander M. Menzies, Jennifer L. McQuade, Matthew D. Hellmann, Lisa Zimmer, Simone M. Goldinger, Georgina V. Long, Lavinia Spain, Justine V. Cohen, Martin Tio, Michael Millward, Douglas B. Johnson, John J. Park, Rajat Rai, Desmond Yip, Chloe Khoo, Samra Turajlic, Anthony M. Joshua

المصدر: Eur J Cancer

مصطلحات موضوعية: 0301 basic medicine, Graft Rejection, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, HIV Infections, Pembrolizumab, Gastroenterology, Organ transplantation, Article, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Hepatitis B, Chronic, Postoperative Complications, Internal medicine, Neoplasms, medicine, Humans, Molecular Targeted Therapy, Melanoma, Aged, Retrospective Studies, Hepatitis, business.industry, Cancer, Immunotherapy, Hepatitis C, Hepatitis B, Hepatitis C, Chronic, Middle Aged, medicine.disease, Transplant Recipients, Neoplasm Proteins, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, business, Viral load

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88ca2382f6383ee824a1796afdc859feTest
https://europepmc.org/articles/PMC10176037Test/